Phase II study with weekly 24-hour infusion (24-h inf.) of high-dose 5-fluorouracil (5-FU) and gemcitabine (GEM) in metastatic pancreas cancer (UICC IVb): final results. - Wein,A.; Wehler,M.; Fischer,B. (Proc Am Soc Clin Oncol, 2002)